Inivata Ltd
Inivata is leading the liquid biopsy revolution and transforming the lives of cancer patients. Our technology is based on pioneering research from the Cancer Research UK Cambridge Institute, University of Cambridge and reinforced by multiple high calibre publications. Our lead product, InVisionFirst®-Lung, is commercially available and provides molecular insights that enable clinicians to make more informed treatment decisions for advanced NSCLC patients. Inivata is partnering with pharmaceutical and biotechnology companies on InVisionFirst-Lung and our wider platform, which is applicable to a range of cancer types. We have a CLIA certified, CAP accredited laboratory in Research Triangle Park, NC, USA and R&D laboratories in Cambridge, UK.
Company details
Find locations served, office locations
- Business Type:
- Technology
- Industry Type:
- Medical Research
- Market Focus:
- Globally (various continents)
About Us
We are transforming the lives of cancer patients and their families through the power of liquid biopsy
We recognize the value of working together as a team, towards a common goal. As a team, our people help to shape the vision, culture, and direction of our company.
We aim to provide the highest standards of training and development, so that people working here are given the opportunity to advance their careers, as we look forward together to advance clinical outcomes and patient care. We provide a rewarding working environment, to accomplish great things, and to help cancer patients and their families.